Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Wantuming Biological Products is a China-based manufacturer of bioactive ingredients focused primarily on chondroitin sulfate and collagen peptide products. Founded in 2005 and located in Laixi, Qingdao, the company operates as an integrated production, sales, and import-export enterprise serving pharmaceutical, nutraceutical, and health ingredient markets. Its public materials emphasize large-scale manufacturing, GMP-oriented quality systems, and multiple quality certifications including NSF-GMP, FSSC22000, ISO9001, and ISO14001, with additional USP-related certification announced in 2025. The business appears to be centered on commercial supply of functional and health-related ingredients rather than a therapeutic drug pipeline. Facilities described by the company include R&D, testing, pilot, extraction, purified production, cold storage, warehousing, and wastewater treatment infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Wantuming Biological Products.